Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003091
What this trial is testing

High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma

Who this might be right for
Kidney CancerMelanoma (Skin)
Hoag Memorial Hospital Presbyterian 40
Not applicableStudy completedNCT00617799
What this trial is testing

Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma

Who this might be right for
Kidney CancerMelanoma (Skin)
University of Nebraska 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT01134614
What this trial is testing

Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Advanced MelanomaMetastatic MelanomaRecurrent Melanoma+6 more
National Cancer Institute (NCI) 245
Testing effectiveness (Phase 2)Study completedNCT00005949
What this trial is testing

Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00074308
What this trial is testing

Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers

Who this might be right for
Recurrent MelanomaStage III MelanomaStage IV Melanoma+1 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)UnknownNCT00116363
What this trial is testing

Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma

Who this might be right for
Malignant MelanomaNeoplasm Metastasis
Introgen Therapeutics 25
Testing effectiveness (Phase 2)Study completedNCT00039325
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Jonsson Comprehensive Cancer Center 28
Early research (Phase 1)Study completedNCT01131234
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+49 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT01740557
What this trial is testing

Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma

Who this might be right for
Metastatic MelanomaStage III Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT02857569
What this trial is testing

A Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic Melanoma

Who this might be right for
Stage III/IV Melanoma
Gustave Roussy, Cancer Campus, Grand Paris 90
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00098553
What this trial is testing

Everolimus in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Alliance for Clinical Trials in Oncology 53
Large-scale testing (Phase 3)Study completedNCT01989572
What this trial is testing

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

Who this might be right for
Iris MelanomaMedium/Large Size Posterior Uveal MelanomaMucosal Melanoma+17 more
National Cancer Institute (NCI) 815
Testing effectiveness (Phase 2)Study completedNCT00053781
What this trial is testing

Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Who this might be right for
Melanoma (Skin)
NCIC Clinical Trials Group 18
Not applicableLooking for participantsNCT05837767
What this trial is testing

Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Who this might be right for
Invasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more
Memorial Sloan Kettering Cancer Center 26
Not applicableUnknownNCT04628806
What this trial is testing

Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells

Who this might be right for
Melanoma Stage IVSarcomaSquamous Cell Carcinoma+3 more
Charite University, Berlin, Germany 120
Large-scale testing (Phase 3)Looking for participantsNCT05727904
What this trial is testing

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Who this might be right for
Metastatic MelanomaUnresectable MelanomaMelanoma
Iovance Biotherapeutics, Inc. 670
Large-scale testing (Phase 3)Study completedNCT00769704
What this trial is testing

Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma

Who this might be right for
Melanoma
BioVex Limited 437
Early research (Phase 1)Ended earlyNCT03865212
What this trial is testing

Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Choroid Melanoma+10 more
Mayo Clinic 12
Early research (Phase 1)Study completedNCT00698100
What this trial is testing

Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines

Who this might be right for
MelanomaSkin
Memorial Sloan Kettering Cancer Center 18
Next Page